companydata.dkCAND.PHARM. POVL M. ASSENS FOND: Financial statements 2023
CVR: 14536604
CAND.PHARM. POVL M. ASSENS FOND (CVR 14536604) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 0 and a net result of DKK 7,149,344 compared with DKK -3,324,757 the year before. Equity amounted to DKK 107,115,532. The solvency ratio was 97.3%. The company had 53 employees in the financial year.
- Revenue
- 0 kr.
- Gross Profit
- 0 kr.
- Profit/Loss
- 7,149,344 kr.
- Equity
- 107,115,532 kr.
- Total Assets
- 110,046,045 kr.
- Employees
- 53
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 0 | 0 | 7.1 mio. | 107.1 mio. | 53 |
| 2022 | - | - | -3.3 mio. | 101.7 mio. | 47 |
| 2021 | 0 | 0 | 7.3 mio. | 106.1 mio. | 41 |
| 2020 | 0 | 0 | 145 t. | 101.2 mio. | 37 |
| 2019 | 0 | 0 | 4.9 mio. | 102.9 mio. | 36 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
CAND.PHARM. POVL M. ASSENS FOND has published its annual report for 2022. The net result was DKK -3,324,757.
About CAND.PHARM. POVL M. ASSENS FOND
CAND.PHARM. POVL M. ASSENS FOND is a Danish company of the type Erhvervsdrivende fond based in Glostrup, founded in 1999. The company is registered under the industry Støtteaktiviteter relateret til sygdomsbekæmpende, sociale og velgørende formål. The company has 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 13,153,000 compared with DKK 11,790,112 the year before. Equity amounted to DKK 128,614,000.